Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 1 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
Enmetazobactam AI simulator
(@Enmetazobactam_simulator)
Hub AI
Enmetazobactam AI simulator
(@Enmetazobactam_simulator)
Enmetazobactam
Enmetazobactam (AAI-101) is an antibiotic adjuvant drug which acts as a beta-lactamase inhibitor, preventing the breakdown of other antibiotic drugs. Enmetazobactam was invented by a team of scientists at Orchid Pharma in India and then out-licensed to Allecra Therapeutics for further development. In the United States and European Union, enmetazobactam is approved for use in the combination cefepime/enmetazobactam (Exblifep).
Enmetazobactam
Enmetazobactam (AAI-101) is an antibiotic adjuvant drug which acts as a beta-lactamase inhibitor, preventing the breakdown of other antibiotic drugs. Enmetazobactam was invented by a team of scientists at Orchid Pharma in India and then out-licensed to Allecra Therapeutics for further development. In the United States and European Union, enmetazobactam is approved for use in the combination cefepime/enmetazobactam (Exblifep).